Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479648
Status:
COMPLETED
Last Update Posted:
2016-07-19
First Post:
2007-05-25
Brief Title:
A Phase 2 Study of Immunogenicity Safety and Tolerability of CSL412 in Elderly Participants
Sponsor:
Seqirus
Organization:
Seqirus
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Influenza |
Keywords: